| scholarly article | Q13442814 |
| P50 | author | Arvind H Patel | Q88999995 |
| P2093 | author name string | T Jake Liang | |
| Miriam Triyatni | |||
| Bertrand Saunier | |||
| Theo Heller | |||
| Luca Ulianich | |||
| Leonard D Kohn | |||
| Anthony R Davis | |||
| Padma Maruvada | |||
| P2860 | cites work | Characterization of pseudotype VSV possessing HCV envelope proteins | Q40598617 |
| Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. | Q40791868 | ||
| Purified recombinant rotavirus VP7 forms soluble, calcium-dependent trimers | Q40842168 | ||
| Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. | Q40898290 | ||
| Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis. | Q40963427 | ||
| Low density lipoprotein receptor as a candidate receptor for hepatitis C virus | Q40972546 | ||
| Calcium is required in reassembly of bovine papillomavirus in vitro | Q41039765 | ||
| Hepatitis C virus: detection of intracellular virus particles by electron microscopy | Q41235560 | ||
| Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). | Q42494871 | ||
| Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins | Q42978052 | ||
| Association of hepatitis C virus in human sera with beta-lipoprotein | Q42982426 | ||
| A role for hepatitis C virus infection in type II cryoglobulinemia | Q42983385 | ||
| Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient | Q42991354 | ||
| Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology | Q42997613 | ||
| The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines | Q43034754 | ||
| The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis | Q43035602 | ||
| Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding | Q43038635 | ||
| Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation | Q43048647 | ||
| Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells | Q45740287 | ||
| Destabilization of herpes simplex virus type 1 virions by local anesthetics, alkaline pH, and calcium depletion | Q45844938 | ||
| Calcium is essential for the structural integrity of the cysteine-rich, ligand-binding repeat of the low-density lipoprotein receptor | Q74248737 | ||
| Binding of hepatitis C virus to CD81 | Q22004178 | ||
| Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. | Q22010245 | ||
| Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. | Q24524809 | ||
| Structure-function analysis of hepatitis C virus envelope-CD81 binding | Q24525189 | ||
| Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor | Q27469307 | ||
| A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. | Q27469530 | ||
| Hepatitis C virus structural proteins assemble into viruslike particles in insect cells | Q27469539 | ||
| Cell fusion activity of hepatitis C virus envelope proteins | Q27469594 | ||
| Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients | Q27469952 | ||
| Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines | Q27472837 | ||
| Formation of native hepatitis C virus glycoprotein complexes. | Q27480776 | ||
| Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | Q27485143 | ||
| Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions | Q27485145 | ||
| Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor | Q27485871 | ||
| Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses | Q27485996 | ||
| Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes | Q27486195 | ||
| Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor | Q27625317 | ||
| Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA | Q27860484 | ||
| Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium | Q29619747 | ||
| Replication of hepatitis C virus | Q29620645 | ||
| Ultrastructural observations in hepatitis C virus-infected lymphoid cells | Q30669466 | ||
| A 50-kDa membrane protein mediates sialic acid-independent binding and infection of conjunctival cells by adenovirus type 37. | Q31807075 | ||
| Folding, assembly and subcellular localization of hepatitis C virus glycoproteins | Q33791619 | ||
| Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment | Q33812492 | ||
| Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion | Q33849237 | ||
| Mechanisms of enveloped virus entry into animal cells | Q33933319 | ||
| The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. | Q34051754 | ||
| Role of Ca2+in the replication and pathogenesis of rotavirus and other viral infections | Q34054013 | ||
| Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells | Q34112888 | ||
| Physical interaction of human papillomavirus virus-like particles with immune cells | Q38301730 | ||
| Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. | Q39550765 | ||
| Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. | Q39577044 | ||
| Biochemical requirements of virus wrapping by the endoplasmic reticulum: involvement of ATP and endoplasmic reticulum calcium store during envelopment of African swine fever virus. | Q39589504 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 9335-9344 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry | |
| P478 | volume | 76 |
| Q45722093 | A model for the study of hepatitis C virus entry |
| Q33886707 | A new model to produce infectious hepatitis C virus without the replication requirement |
| Q41981846 | A plant-derived dehydrorotenoid: a new inhibitor of hepatitis C virus entry |
| Q27490785 | Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry |
| Q33850594 | An in vitro model of hepatitis C virion production |
| Q27468952 | Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway |
| Q27473044 | Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients |
| Q35546564 | Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents |
| Q36385222 | Cell entry of hepatitis C virus |
| Q40555914 | Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins |
| Q38352468 | Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate |
| Q91900521 | Chapter 22. Non-HIV antiviral agents |
| Q40539381 | Characterization of functional hepatitis C virus envelope glycoproteins. |
| Q40558556 | Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection |
| Q37834097 | Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies |
| Q40445144 | Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles |
| Q37201846 | Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems |
| Q43041371 | Effect of chronic hepatitis C virus infection on inflammatory lipid mediators |
| Q34992715 | Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77. |
| Q40097907 | Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles |
| Q35621603 | Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation |
| Q35059730 | Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. |
| Q33867009 | HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro. |
| Q27001610 | Hepatitis C virus and vaccine development |
| Q36326835 | Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture |
| Q36581588 | Hepatitis C virus entry: molecular biology and clinical implications |
| Q34016463 | Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy |
| Q41682985 | Hepatitis C virus: The role of N-glycosylation sites of viral genotype 1b proteins for formation of viral particles in insect and mammalian cells. |
| Q42999970 | High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. |
| Q38332447 | High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. |
| Q40275014 | Host cell responses induced by hepatitis C virus binding. |
| Q34437763 | Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity |
| Q40150500 | Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry |
| Q38843888 | Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes |
| Q40409464 | Improved attachment of natural HCV isolate to Daudi cells upon elimination of immune complexes and close pH control |
| Q24673768 | Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes |
| Q30376236 | Influenza vaccines based on virus-like particles |
| Q30767073 | Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. |
| Q35821487 | Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus |
| Q26740106 | Intracellular targeting with engineered proteins |
| Q42801918 | Liver cell lines for the study of hepatocyte functions and immunological response |
| Q39405740 | Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q36759971 | MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells |
| Q40106501 | Mitogen-activated protein kinase signalling pathways triggered by the hepatitis C virus envelope protein E2: implications for the prevention of infection |
| Q43035003 | Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection |
| Q34558519 | Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system |
| Q39092405 | Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro. |
| Q34366406 | NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system |
| Q35231331 | Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2 |
| Q36179699 | Neutralizing antibodies in hepatitis C virus infection |
| Q36921336 | New therapeutic opportunities for hepatitis C based on small RNA. |
| Q27473046 | Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients |
| Q34605727 | Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli |
| Q36933791 | Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle |
| Q27473066 | Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. |
| Q27469468 | Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. |
| Q40630400 | Small molecule inhibition of hepatitis C virus E2 binding to CD81 |
| Q43048241 | Structural characterisation of the hepatitis C envelope glycoprotein E1 ectodomain derived from a mammalian and a yeast expression system |
| Q27481034 | Studying Hepatitis C Virus: Making the Best of a Bad Virus |
| Q38299373 | The role of HCV e2 protein glycosylation in functioning of virus envelope proteins in insect and Mammalian cells |